MissionIR Articles

Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, recently announced that it has been asked to present at the American Association for the Study of Liver Disease…

InVivo Therapeutics, a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and neurotrauma, recently released a letter to Shareholders. The Shareholder letter detailed, among other things, Invivo’s excellent progress in recent…

Issuer Direct, a provider of disclosure management solutions and cloud-based compliance technologies, today reported its financial results for the third quarter of 2012. The company reported GAAP earnings of $213,591, or $0.11 per share, marking…

Keryx Biopharmaceuticals is focused on medically important pharmaceutical products for the treatment of renal disease. The company is currently developing Zerenex (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind phosphate…

Astex Pharmaceuticals announced yesterday it has signed a five-year strategic drug discovery alliance with Cancer Research Technology Limited (CRT) and Newcastle University. As partners, the three entities will discover and develop new cancer drugs in…

Sigma Designs announced that the Comtrend PG-9141s Powerline Single Port Adapter won the 2012 Communications Technologies Platinum Award in home networking, which was announced at the 2012 SCTE Cable-Tec Expo in Orlando. This is significant…

Cleantech Solutions, a leading manufacturer of metal components and assemblies, primarily used in the wind power, solar, and other clean technology industries, announced yesterday that it has received purchase orders for airflow-dyeing machines and related…

Actuate announced the introduction of BIRT iHub, a solution deployment framework for delivering applications that keep end users up to date on the insights they need to run their businesses. BIRT iHub, the newest addition…

CounterPath, a global provider of personal computer and mobile application software as well as gateway server software products, announced today that it will enter into a strategic license royalty agreement with Nippon Telegraph and Telephone…

Uranium Resources, which has in-situ recovered (ISR) over 8M lbs of uranium out of the earth since the company’s inception in the rich Texas Gulf Coast uranium region back in 1977 (now holding four major…

Compugen is a therapeutic product discovery company focused on therapeutic proteins and monoclonal antibodies to address important unmet medical needs in the fields of immunology and oncology. To discover drug candidates, the company utilizes a…

U.S. Geothermal, a company boldly pioneering the most abundant source of renewable energy on the planet, producing electricity from the tapping/harvesting of the planet’s own core temperature, reported signage of a memorandum of understanding to…

ChromaDex, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic, and pharmaceutical industries, announced on October 29, 2012, that it had been…

FluoroPharma Medical, a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography (PET) technology for the detection and assessment of disease before clinical manifestation, recently announced a considerable increase…

Cel-Sci Corp., a late-stage oncology company, is involved in the research and development of immunotherapy products for the treatment of cancer and infectious diseases. The company’s core capabilities include: drug discovery, research, development, and manufacturing…

AtheroNova, through its wholly-owned subsidiary, AtheroNova Operations, is a development stage company currently researching novel patents-pending applications of certain natural compounds to regress atherosclerotic plaque deposits, a process called delipidization. To prepare for human trials,…